When present alongside other cardiovascular risk factors, obesity and type 2 diabetes compound the risk of myocardial infarction, stroke and premature death, escalating both individual and public health burden 5,6
GLP-1RA can be used in patients with hepatic impairment, without dose adjustments, although they have not been extensively studied in these circumstances (71)
As the litigation continues to grow, both sides are preparing for a critical Rule 702 hearing on May 14, 2025, where the admissibility of expert testimony on causation will be challenged
Weight loss often becomes steadier
Understanding the Clinical and BMI Rules Before you start calling your book of business, its crucial to understand exactly who qualifies
Unsupported diagnoses often trigger denials